{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T07:22:07Z","timestamp":1793690527738,"version":"4.5.1"},"reference-count":81,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2004,8,24]],"date-time":"2004-08-24T00:00:00Z","timestamp":1093305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsia"],"published-print":{"date-parts":[[2004,9]]},"abstract":"<jats:p><jats:bold>Summary:\u2002<\/jats:bold> Phenobarbital (PB) is the most widely used antiepileptic drug (AED) in the developing world and remains a popular choice in many industrialized countries. Meta\u2010analyses of randomized controlled trials suggest that few differences in efficacy exist between PB and other established AEDs, but its possible deleterious cognitive and behavioral side effects remain a concern in the developed world. In contrast, high degrees of efficacy and tolerability in everyday clinical use have been demonstrated consistently in observational studies in developing countries. We propose that a pragmatic, comprehensive outcomes program be carried out, perhaps under the aegis of the Global Campaign Against Epilepsy, to optimize the conditions of the use of PB, so that more people around the world can benefit from this cost\u2010effective medication and live more fulfilling lives.<\/jats:p>","DOI":"10.1111\/j.0013-9580.2004.12704.x","type":"journal-article","created":{"date-parts":[[2004,12,23]],"date-time":"2004-12-23T09:18:27Z","timestamp":1103793507000},"page":"1141-1149","source":"Crossref","is-referenced-by-count":222,"title":["Phenobarbital for the Treatment of Epilepsy in the 21st Century: A Critical Review"],"prefix":"10.1111","volume":"45","author":[{"given":"Patrick","family":"Kwan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J.","family":"Brodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,8,24]]},"reference":[{"key":"e_1_2_9_2_2","first-page":"1907","article-title":"Luminal bei Epilepsie","volume":"59","author":"Hauptmann A","year":"1912","journal-title":"Munch Med Wochenschr"},{"key":"e_1_2_9_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02515-0"},{"key":"e_1_2_9_4_2","volume-title":"Initiative of support to people with epilepsy","author":"World Health Organization","year":"1990"},{"key":"e_1_2_9_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(98)80013-7"},{"key":"e_1_2_9_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.4.991"},{"key":"e_1_2_9_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200002033420503"},{"key":"e_1_2_9_8_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.43.s.6.13.x"},{"key":"e_1_2_9_9_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.43.s.6.4.x"},{"key":"e_1_2_9_10_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1989.sp017814"},{"key":"e_1_2_9_11_2","first-page":"223","article-title":"Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds","volume":"42","author":"Rogawski MA","year":"1990","journal-title":"Pharmacol Rev"},{"key":"e_1_2_9_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410250302"},{"key":"e_1_2_9_13_2","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1996.sp021784"},{"key":"e_1_2_9_14_2","first-page":"596","volume-title":"Antiepileptic Drug","author":"Anderson GD","year":"2002"},{"key":"e_1_2_9_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1552-4604.1982.tb02662.x"},{"key":"e_1_2_9_16_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01061382"},{"key":"e_1_2_9_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410220515"},{"key":"e_1_2_9_18_2","first-page":"320","article-title":"Withdrawal of barbiturate anticonvulsant drugs: prospective controlled study","volume":"93","author":"Coulter DL","year":"1988","journal-title":"Am J Ment Retard"},{"key":"e_1_2_9_19_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/122.3.441"},{"key":"e_1_2_9_20_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00191914"},{"key":"e_1_2_9_21_2","first-page":"259","article-title":"Identification of enzymes responsible for the metabolism of phenobarbital","volume":"10","author":"Hargraves JA","year":"1996","journal-title":"Int Soc Stud Xenobiot Proc"},{"key":"e_1_2_9_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/5135"},{"key":"e_1_2_9_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-6147(00)01717-X"},{"key":"e_1_2_9_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1995.tb06007.x"},{"key":"e_1_2_9_25_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200204000-00010"},{"key":"e_1_2_9_26_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050703"},{"key":"e_1_2_9_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-200104000-00004"},{"key":"e_1_2_9_28_2","doi-asserted-by":"publisher","DOI":"10.1097\/00019052-200304000-00013"},{"key":"e_1_2_9_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3940(02)00423-8"},{"key":"e_1_2_9_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1525-5050(02)00511-5"},{"key":"e_1_2_9_31_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.103.049858"},{"key":"e_1_2_9_32_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.050585397"},{"key":"e_1_2_9_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00008571-200102000-00002"},{"key":"e_1_2_9_34_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.2902"},{"key":"e_1_2_9_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(02)02235-5"},{"key":"e_1_2_9_36_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2002.13001.x"},{"key":"e_1_2_9_37_2","first-page":"504","volume-title":"Antiepileptic drugs","author":"Leeder JS","year":"2002"},{"key":"e_1_2_9_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1980.72"},{"key":"e_1_2_9_39_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1994.tb04375.x"},{"key":"e_1_2_9_40_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.30.1.94"},{"key":"e_1_2_9_41_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1980.tb01505.x"},{"key":"e_1_2_9_42_2","first-page":"317","article-title":"Pharmacological implications of microsomal enzyme induction","volume":"19","author":"Conney AH","year":"1967","journal-title":"Pharmacol Rev"},{"key":"e_1_2_9_43_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.17332"},{"key":"e_1_2_9_44_2","doi-asserted-by":"publisher","DOI":"10.1038\/35038112"},{"key":"e_1_2_9_45_2","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.2000.3557"},{"key":"e_1_2_9_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601183340308"},{"key":"e_1_2_9_47_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)90074-4"},{"key":"e_1_2_9_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1998.tb01167.x"},{"key":"e_1_2_9_49_2","doi-asserted-by":"publisher","DOI":"10.1159\/000071219"},{"key":"e_1_2_9_50_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.49.2.333"},{"key":"e_1_2_9_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)09102-8"},{"key":"e_1_2_9_52_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200006223422511"},{"key":"e_1_2_9_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1059-1311(03)00047-5"},{"key":"e_1_2_9_54_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198507183130303"},{"key":"e_1_2_9_55_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.58.1.44"},{"key":"e_1_2_9_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)06250-8"},{"key":"e_1_2_9_57_2","first-page":"1","article-title":"Phenobarbitone versus phenytoin monotherapy for partial onset seizures and generalized onset tonic\u2010clonic seizures","author":"Taylor S","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_58_2","first-page":"3","article-title":"Carbamazepine versus phenobarbitone monotherapy for epilepsy","author":"Tudur Smith C","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_2_9_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0920-1211(93)90048-C"},{"key":"e_1_2_9_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)91176-U"},{"key":"e_1_2_9_61_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1992.tb02341.x"},{"key":"e_1_2_9_62_2","doi-asserted-by":"publisher","DOI":"10.1179\/027249302125001598"},{"key":"e_1_2_9_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)04516-5"},{"key":"e_1_2_9_64_2","first-page":"532","article-title":"Treatment with phenobarbital and monitoring of epileptic patients in rural Mali","volume":"80","author":"Nimaga K","year":"2002","journal-title":"Bull WHO"},{"key":"e_1_2_9_65_2","first-page":"528","volume-title":"Antiepileptic drugs","author":"Baulac M","year":"2002"},{"key":"e_1_2_9_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03600-X"},{"key":"e_1_2_9_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1995.03530190032031"},{"key":"e_1_2_9_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(79)80507-7"},{"key":"e_1_2_9_69_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002083220604"},{"key":"e_1_2_9_70_2","doi-asserted-by":"publisher","DOI":"10.1177\/000992289903800702"},{"key":"e_1_2_9_71_2","doi-asserted-by":"publisher","DOI":"10.1542\/peds.80.2.165"},{"key":"e_1_2_9_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1987.tb03623.x"},{"key":"e_1_2_9_73_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.3_Part_1.391"},{"key":"e_1_2_9_74_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528-1157.1996.tb00516.x"},{"key":"e_1_2_9_75_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.2001.04501.x"},{"key":"e_1_2_9_76_2","volume-title":"Manage Sci Health","author":"International Drug Price Indicator Guide","year":"2003"},{"key":"e_1_2_9_77_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528-1157.43.s.6.14.x"},{"key":"e_1_2_9_78_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000059867.35547.DE"},{"key":"e_1_2_9_79_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1229"},{"key":"e_1_2_9_80_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021986"},{"key":"e_1_2_9_81_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000096940.92986.02"},{"key":"e_1_2_9_82_2","first-page":"1547","volume-title":"Epilepsy: a comprehensive textbook","author":"Eadie MJ","year":"1997"}],"container-title":["Epilepsia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.0013-9580.2004.12704.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.0013-9580.2004.12704.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T20:38:18Z","timestamp":1697315898000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.0013-9580.2004.12704.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8,24]]},"references-count":81,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["10.1111\/j.0013-9580.2004.12704.x"],"URL":"https:\/\/doi.org\/10.1111\/j.0013-9580.2004.12704.x","archive":["Portico"],"relation":{},"ISSN":["0013-9580","1528-1167"],"issn-type":[{"value":"0013-9580","type":"print"},{"value":"1528-1167","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8,24]]}}}